Ming Jin1, Joseph Jakowski2, Paul E Wakely3. 1. Department of Pathology, The Ohio State University Wexner Medical Center, 405 Doan Hall, 410 West 10th Avenue, Columbus, Ohio. 2. Department of Pathology, Virginia Commonwealth University, Richmond, Virginia. 3. Department of Pathology, The Ohio State University Wexner Medical Center, 405 Doan Hall, 410 West 10th Avenue, Columbus, Ohio. Electronic address: paul.wakely@osumc.edu.
Abstract
BACKGROUND: Anaplastic thyroid carcinoma (ATC) is relatively rare. A correct pathologic diagnosis is mandatory to exclude less aggressive entities, and guide management. We describe our experience with the fine needle aspiration (FNA) cytomorphology of ATC and potential mimics. MATERIALS AND METHODS: Cytology files were searched to recover all cases of ATC/suspicious for ATC. Surgical pathology files were searched for ATC cases having corresponding cytology. FNA was performed using standard technique. RESULTS: Of 59 FNA cases, 34 were correctly diagnosed as ATC (or possible ATC); 22 were false negative, and 3 false positive. All but 2 patients were confirmed by tissue biopsy or clinical course. Of 56 true ATC cases [51 patients (mean age: 69 years) (F:M ratio: 1.24:1)], 40 were primary, 11 metastatic, 4 recurrent, and 1 indeterminate. Carcinoma not otherwise specified (6), malignant not otherwise specified (5), differentiated thyroid cancer (3), atypical (2), suspicious for neoplasm/malignancy (2), and unsatisfactory (4) constituted the false negative diagnoses. Smear cellularity and cell distribution were variable. Malignant cells were mostly epithelioid, but accompanied by pleomorphic, spindle, and multinucleated forms. Differentiated thyroid carcinoma was diagnosed in 5 cases. Background necrosis and/or inflammation were common (80%). Three false positive cases included 1 example each of melanoma, Hürthle cell carcinoma, and metastatic squamous carcinoma. Where follow-up was possible, 91% of patients were dead of disease. CONCLUSION: A FNA diagnosis of ATC/probable ATC was made in 34 out of 56 cases (sensitivity: 61%). Problematic cases were associated with incomplete sampling, lack of cell block immunostaining, uncertainty of anatomic site, and overlapping morphologic features with non-ATC malignancies.
BACKGROUND:Anaplastic thyroid carcinoma (ATC) is relatively rare. A correct pathologic diagnosis is mandatory to exclude less aggressive entities, and guide management. We describe our experience with the fine needle aspiration (FNA) cytomorphology of ATC and potential mimics. MATERIALS AND METHODS: Cytology files were searched to recover all cases of ATC/suspicious for ATC. Surgical pathology files were searched for ATC cases having corresponding cytology. FNA was performed using standard technique. RESULTS: Of 59 FNA cases, 34 were correctly diagnosed as ATC (or possible ATC); 22 were false negative, and 3 false positive. All but 2 patients were confirmed by tissue biopsy or clinical course. Of 56 true ATC cases [51 patients (mean age: 69 years) (F:M ratio: 1.24:1)], 40 were primary, 11 metastatic, 4 recurrent, and 1 indeterminate. Carcinoma not otherwise specified (6), malignant not otherwise specified (5), differentiated thyroid cancer (3), atypical (2), suspicious for neoplasm/malignancy (2), and unsatisfactory (4) constituted the false negative diagnoses. Smear cellularity and cell distribution were variable. Malignant cells were mostly epithelioid, but accompanied by pleomorphic, spindle, and multinucleated forms. Differentiated thyroid carcinoma was diagnosed in 5 cases. Background necrosis and/or inflammation were common (80%). Three false positive cases included 1 example each of melanoma, Hürthle cell carcinoma, and metastatic squamous carcinoma. Where follow-up was possible, 91% of patients were dead of disease. CONCLUSION: A FNA diagnosis of ATC/probable ATC was made in 34 out of 56 cases (sensitivity: 61%). Problematic cases were associated with incomplete sampling, lack of cell block immunostaining, uncertainty of anatomic site, and overlapping morphologic features with non-ATC malignancies.
Authors: Peter Podany; Rita Abi-Raad; Andrea Barbieri; James Garritano; Manju L Prasad; Guoping Cai; Adebowale J Adeniran; Syed M Gilani Journal: Am J Clin Pathol Date: 2022-04-01 Impact factor: 5.400
Authors: Antonio Matrone; Luigi De Napoli; Liborio Torregrossa; Aleksandr Aghababyan; Piermarco Papini; Carlo Enrico Ambrosini; Rosa Cervelli; Clara Ugolini; Fulvio Basolo; Eleonora Molinaro; Rossella Elisei; Gabriele Materazzi Journal: Front Oncol Date: 2022-04-05 Impact factor: 5.738
Authors: Vincent Vander Poorten; Nathan Goedseels; Asterios Triantafyllou; Alvaro Sanabria; Paul M Clement; Oded Cohen; Pawel Golusinski; Orlando Guntinas-Lichius; Cesare Piazza; Gregory W Randolph; Alessandra Rinaldo; Ohad Ronen; Maria E Cabanillas; Ashok R Shaha; Yong Teng; Ralph P Tufano; Michelle D Williams; Mark Zafereo; Alfio Ferlito Journal: Front Endocrinol (Lausanne) Date: 2022-09-20 Impact factor: 6.055
Authors: Keith C Bible; Electron Kebebew; James Brierley; Juan P Brito; Maria E Cabanillas; Thomas J Clark; Antonio Di Cristofano; Robert Foote; Thomas Giordano; Jan Kasperbauer; Kate Newbold; Yuri E Nikiforov; Gregory Randolph; M Sara Rosenthal; Anna M Sawka; Manisha Shah; Ashok Shaha; Robert Smallridge; Carol K Wong-Clark Journal: Thyroid Date: 2021-03 Impact factor: 6.568